Diabetes, statins and cardiovascular disease

被引：0
|
作者：
Jackson, G
机构：
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2001年 / 55卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：291 / 291
页数：1
相关论文
共 50 条
  • [41] Starting statins for primary prevention of cardiovascular disease
    Tunstall-Pedoe, Hugh
    HEART, 2013, 99 (21) : 1547 - 1548
  • [42] Optimal Prescribing of Statins to Reduce Cardiovascular Disease
    Schade, David S.
    Duro, Teodor
    Eaton, R. Philip
    AMERICAN JOURNAL OF MEDICINE, 2023, 136 (12): : 1133 - 1135
  • [43] Statins, ACE inhibitors and ARBs in cardiovascular disease
    Montecucco, Fabrizio
    Mach, Francois
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (03) : 389 - 400
  • [44] IS STATINS FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IS A SCAM?
    Arathi, T., V
    Santhosh, Neenu Rachel
    Padmakumar, Sreelakshmi
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 202 - 204
  • [45] Statins for the primary prevention of cardiovascular disease in women?
    Birge, Stanley J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (12): : 1287 - 1288
  • [46] Statins for people at low risk of cardiovascular disease
    Mascitelli, Luca
    Goldstein, Mark R.
    LANCET, 2012, 380 (9856): : 1816 - 1816
  • [47] The role of statins in primary prevention of cardiovascular disease
    Eichler, Klaus
    Puhan, Milo A.
    Bachmann, Lucas M.
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (10) : 1100 - 1100
  • [48] Statins for Primary Prevention of Cardiovascular Disease RESPONSE
    Yebyo, Henock G.
    Aschmann, Helene E.
    Puhan, Milo A.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (01) : 74 - 76
  • [49] Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins
    Kawada, Tomoyuki
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 569 - 570
  • [50] Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins
    Tomoyuki Kawada
    Cardiovascular Drugs and Therapy, 2022, 36 : 569 - 570
12345